URAC Specialty Pharmacy Small Business Accreditation Consulting — Integral Healthcare Solutions

Last updated: April 2026

IHS guides independent and community specialty pharmacies through URAC's Small Business Specialty Pharmacy Accreditation program — the streamlined three-year quality credential designed for smaller organizations that need payer network access to compete in the specialty drug market. With direct URAC expertise led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, IHS provides the standard-by-standard guidance that turns a complex accreditation process into a six-month execution plan.

What Is URAC Specialty Pharmacy Small Business Accreditation?

URAC Specialty Pharmacy Small Business Accreditation is URAC's dedicated pathway for independent, community, and privately held specialty pharmacies that meet URAC's small business eligibility criteria. It is not a lesser credential — it is the same three-year quality recognition as URAC's full Specialty Pharmacy Accreditation, built on the same nine operational modules, with modified fee structures and self-reporting options that make the program accessible to smaller organizations.

The credential signals to payers, PBMs, and drug manufacturers that your pharmacy operates to national quality standards — the prerequisite for specialty drug network participation, limited distribution drug access, and competitive payer contracts. Approximately 66% of commercial payers prefer URAC accreditation for specialty pharmacy network inclusion, and major PBMs including OptumRx, CVS Caremark, and Express Scripts use it as a condition of network entry.

The current URAC Specialty Pharmacy standard is version 6.0, announced October 2025, succeeding version 5.0 which was active from October 2022. IHS prepares organizations against the current operative standard, not prior versions.

The Nine Standards Modules

Both the full and Small Business programs are organized around nine operational modules. Each module defines specific requirements your pharmacy must demonstrate to earn accreditation and sustain it through the three-year cycle.

  • Risk Management (RM) — infrastructure for identifying, assessing, and managing clinical and operational risk
  • Operations and Infrastructure (OPIN) — organizational governance, staffing, credentialing of pharmacy personnel, and physical plant requirements
  • Performance Monitoring and Improvement (PMI) — quality measurement, data collection, and continuous improvement programs
  • Consumer Protection and Empowerment (CPE) — patient rights, grievance processes, and consumer information requirements
  • Pharmacy Operations (P-OPS) — policies, procedures, and operational controls governing specialty dispensing activities
  • Medication Distribution (P-MD) — safe, accurate, and compliant specialty medication dispensing and delivery
  • Patient Service and Communication (P-PSC) — patient outreach, education, medication counseling, and adherence support
  • Patient Management (PM) — clinical oversight, therapy management, and coordination with prescribers and payers
  • Reporting Performance Measures (RPT) — data submission and annual quality measure reporting to URAC

Small Business vs. Full Specialty Pharmacy Accreditation

The Small Business program applies the same nine-module standards framework as the full program. The distinctions lie in three areas: eligibility (revenue-based qualification criteria set by URAC), fee structure (reduced application and accreditation fees for qualifying organizations), and self-reporting options (qualifying small businesses may self-report certain quality metrics rather than submitting to third-party data collection). The accreditation outcome — a three-year URAC Specialty Pharmacy credential — is identical. Payers and PBMs recognize both equally.

Who Needs URAC Specialty Pharmacy Small Business Accreditation?

If your pharmacy dispenses specialty medications and operates below URAC's revenue threshold for small business eligibility, the Small Business program is your entry point to the URAC credential. The organizations that benefit most are:

  • Independent specialty pharmacies — entering specialty drug networks for the first time and facing PBM network access requirements
  • Community pharmacies adding specialty lines — expanding into specialty dispensing and needing the credential to execute manufacturer and payer contracts
  • Startup specialty pharmacies — launching operations and building the accreditation credential as a foundational market entry step
  • Infusion and home infusion pharmacies — adding specialty oral dispensing and needing URAC recognition alongside existing operational credentials
  • Compounding pharmacies entering specialty — transitioning into commercially manufactured specialty products and the associated network requirements
  • 340B-covered entity pharmacies — contract pharmacies that need URAC accreditation to access manufacturer specialty programs and payer contracts

The market reality for independent specialty pharmacies is stark: PBM-affiliated chains hold a commanding share of specialty drug revenue. Independent pharmacies represent the largest group by dispensing location count but face a steadily shrinking revenue share. The differentiator is network access — and network access requires accreditation. For independent specialty pharmacies, the URAC Small Business program is not optional infrastructure. It is the ticket to the market.

The URAC Specialty Pharmacy Accreditation Process

URAC states that specialty pharmacy accreditation can be achieved in six months or less from application. IHS structures the engagement to hit that timeline with a four-phase approach that front-loads gap identification so documentation work is targeted, not speculative.

Phase 1: Gap Assessment and Standards Orientation (Weeks 1–4)

IHS performs a standard-by-standard review of your current operations against all nine URAC modules. This is the most important phase: gaps identified early can be remediated during the accreditation window; gaps identified at application review cannot. We produce a written gap report with findings ranked by severity and remediation sequencing — the document that drives every subsequent phase.

During this phase you obtain the URAC standards documents from the URAC store, request a URAC consultation, and begin the application agreement process. IHS coordinates directly with your leadership team on the URAC pre-application steps.

Phase 2: Policy, Procedure, and Documentation Development (Weeks 4–16)

IHS provides templates for all required documentation across all nine modules — risk management plans, pharmacy operations policies, patient management protocols, consumer protection procedures, quality measurement frameworks, and performance reporting templates. Your team adapts these templates to your specific operations and begins generating the evidence record that URAC will review.

This phase also covers the operational infrastructure requirements: staff credentialing files, quality committee meeting documentation, patient communication logs, medication distribution records, and the performance measure data collection system your pharmacy must have in place before application submission.

Phase 3: Mock Review and Evidence Validation (Weeks 16–20)

IHS conducts a structured mock review simulating the URAC desktop review process. We audit your documentation against the nine-module standards, test the completeness and internal consistency of your evidence record, and identify any remaining gaps before application submission. This phase catches the deficiencies that would otherwise produce post-submission Requests for Information (RFIs) — which extend your timeline and create remediation work under time pressure.

Phase 4: Application Submission and Post-Submission Support (Weeks 20–26)

IHS supports the formal application submission — evidence packaging, reviewer coordination, and response to any URAC inquiries during the review process. If URAC issues RFIs, IHS provides direct drafting support to resolve them within URAC's response windows. The accreditation committee review is the final step; once passed, your three-year URAC Specialty Pharmacy credential is issued.

Mid-Cycle Maintenance

URAC Specialty Pharmacy Accreditation is a three-year credential with ongoing monitoring requirements. Your pharmacy must collect and submit annual quality measure data. URAC may conduct a mid-cycle onsite review with 14 days' notice to confirm ongoing compliance. IHS advises on mid-cycle maintenance protocols and can support mid-cycle review preparation separately from the initial accreditation engagement.

Why Payer Network Access Requires URAC Accreditation

The specialty pharmacy market runs on network access. PBMs control which pharmacies can dispense specialty drugs under commercial, Medicare Part D, and Medicaid managed care plans. They use accreditation — specifically URAC — as the gatekeeping criterion because it signals operational quality without requiring the PBM to conduct its own pharmacy audit for every network application.

What Accreditation Unlocks

  • PBM network participation — OptumRx contractually requires URAC, ACHC, or TJC accreditation for specialty pharmacy network entry. CVS Caremark and Express Scripts maintain equivalent requirements. Without accreditation, your pharmacy cannot contract as a specialty provider.
  • Limited distribution drug access — pharmaceutical manufacturers designate specialty pharmacies for limited distribution drugs (LDDs), often requiring URAC accreditation as a condition of designation. LDDs carry the highest specialty drug margins.
  • Payer reimbursement — some commercial payers will only reimburse specialty drug claims dispensed by a URAC-accredited pharmacy, regardless of whether the pharmacy is otherwise in the plan's network.
  • Manufacturer hub program eligibility — manufacturer-sponsored patient support programs and co-pay assistance programs increasingly require pharmacy partners to hold current URAC specialty pharmacy accreditation.
  • Competitive contracting position — health systems, employer health plans, and self-insured employers that negotiate narrow pharmacy networks use URAC accreditation as a qualifying criterion, not a tie-breaker.

The Independent Pharmacy Competitive Position

Independent specialty pharmacies hold a structural advantage that the Small Business accreditation program is designed to activate. Independent pharmacies typically provide higher-touch patient management, faster prior authorization turnaround, and more responsive clinical support than PBM-affiliated chains. The URAC credential documents that patient care quality through a standardized national framework — converting a competitive strength into a verifiable credential that payers and manufacturers can rely on for network decisions.

The risk of not pursuing accreditation is asymmetric. Payers are not reducing accreditation requirements — they are expanding them. A pharmacy that defers accreditation loses network access as requirements tighten, then faces the accreditation process from a position of competitive disadvantage rather than competitive strength.

Why IHS for URAC Specialty Pharmacy Small Business Accreditation

IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC. No consulting firm has deeper institutional knowledge of how URAC standards are written, how the accreditation committee evaluates evidence, and where pharmacies encounter the deficiencies that produce RFIs and failed reviews.

What IHS Brings to the Engagement

  • Insider standards interpretation — URAC standards are written by committees and interpreted by reviewers with specific analytical frameworks. IHS knows what the standard actually requires, not just what it says on the surface.
  • Nine-module coverage from day one — IHS's gap assessment covers all nine modules simultaneously. No module is treated as low-priority because every module is scored at accreditation review.
  • Template library built on current standards — IHS policy and procedure templates are aligned with the current operative URAC Specialty Pharmacy standard, not legacy versions.
  • Small business program navigation — IHS advises on eligibility determination, fee structure, and self-reporting options specific to the Small Business program — details that differ from the full accreditation pathway in ways that affect your timeline and documentation requirements.
  • RFI prevention through mock review — the mock review phase is designed to surface the exact deficiencies that URAC reviewers look for, before they see your application. An RFI-free submission is the goal of every IHS engagement.
  • Post-accreditation maintenance guidance — IHS advises on the annual quality measure reporting requirements and mid-cycle review protocols that sustain your credential through the three-year cycle.

Adjacent URAC Pharmacy Programs

IHS also consults on the full URAC Specialty Pharmacy Accreditation for larger organizations, URAC Mail Service Pharmacy Accreditation, and URAC Specialty Pharmacy Services Accreditation (for organizations that manage specialty therapy without dispensing). If your organization grows beyond the Small Business eligibility threshold during or after your initial accreditation cycle, IHS manages the transition to the full program.

Common URAC Specialty Pharmacy Accreditation Deficiencies

URAC specialty pharmacy reviews follow predictable failure patterns. Independent and startup pharmacies tend to cluster their deficiencies in the same areas — not because the standards are unclear, but because the documentation infrastructure required to satisfy them is not part of typical independent pharmacy operations. Here are the categories where IHS most frequently identifies gaps.

1. Patient Management Documentation Gaps (PM Module)

The Patient Management module requires documented clinical oversight of specialty patients — therapy initiation assessments, ongoing monitoring protocols, adverse event tracking, and prescriber coordination records. Independent pharmacies often have the clinical activity but lack the documentation structure to demonstrate it to a URAC reviewer. Evidence exists in the pharmacy's workflow but not in a format that satisfies the standard.

2. Quality Measure Data Collection (PMI and RPT Modules)

URAC requires pharmacies to collect, analyze, and report specific quality performance measures. The common failure is not collecting the right data in a retrievable format from the start of the accreditation period. Data collected informally cannot be reconstructed as structured evidence after the fact. IHS installs the measurement framework before the accreditation clock starts.

3. Consumer Protection Procedure Gaps (CPE Module)

The Consumer Protection and Empowerment module requires formal grievance and appeal procedures, patient rights documentation, and consumer information standards that go beyond typical pharmacy disclosure requirements. Independent pharmacies routinely underestimate the specificity of URAC's CPE requirements relative to state pharmacy board requirements.

4. Risk Management Infrastructure (RM Module)

URAC's Risk Management module requires a formal risk management program — not just operational risk awareness. This includes a written risk management plan, designated risk management oversight, documented risk identification and mitigation activities, and evidence of program monitoring. Few independent pharmacies enter the accreditation process with this infrastructure in place.

5. Operations and Infrastructure Credentialing (OPIN Module)

The OPIN module requires documented credentialing of pharmacy personnel — verification of licenses, certifications, and training for pharmacists, technicians, and clinical staff. State pharmacy board requirements do not satisfy URAC's OPIN credentialing documentation requirements. The gap is typically in documentation format and completeness, not in actual staff qualifications.

6. Medication Distribution Protocols (P-MD Module)

Specialty drug distribution requirements — temperature excursion management, cold-chain documentation, specialty packaging validation, and delivery confirmation records — are more prescriptive under URAC standards than under state pharmacy law. Independent pharmacies dispensing specialty biologics and injectables need written protocols that match the URAC standard's specificity.

Frequently Asked Questions

What is URAC Specialty Pharmacy Small Business Accreditation?

URAC Specialty Pharmacy Small Business Accreditation is URAC's streamlined accreditation pathway for independent, community, and privately held specialty pharmacies that meet URAC's revenue-based eligibility criteria. It applies the same nine-module standards framework as the full program, with reduced fees and self-reporting options for qualifying organizations. The resulting credential — a three-year URAC Specialty Pharmacy Accreditation — is recognized equally by payers and PBMs.

How is the Small Business program different from the full program?

The standards modules and the three-year credential are identical. The differences are in eligibility (revenue threshold determined by URAC), application and accreditation fee structure (reduced for qualifying small businesses), and self-reporting options for certain quality metrics. The operational and documentation requirements are substantively equivalent. Contact URAC or IHS to determine whether your organization qualifies.

How long does the accreditation process take?

URAC states accreditation can be achieved in six months or less from application. IHS structures engagements to achieve that timeline by front-loading the gap assessment and documentation work.

What payers require URAC specialty pharmacy accreditation?

OptumRx, CVS Caremark, Express Scripts, and other major PBMs use URAC, ACHC, or TJC accreditation as a condition of specialty pharmacy network participation. Approximately 66% of commercial payers prefer URAC specifically. Some payers will only reimburse specialty drug claims dispensed from an accredited pharmacy.

How much does URAC Specialty Pharmacy accreditation cost?

URAC application and accreditation fees vary by program and organization size and are not publicly listed. Standards documents are available for purchase from the URAC store. IHS consulting engagement fees are scoped per client based on organizational size, current compliance posture, and scope of the engagement — contact us for a proposal.

Can my pharmacy pursue dual accreditation with both URAC and ACHC?

Yes. Many specialty pharmacies pursue dual accreditation to maximize network access across payer systems that prefer different accrediting bodies. URAC covers approximately 66% of commercial payer preferences; ACHC provides additional network access for plans that recognize ACHC specifically. IHS advises on dual accreditation strategy and sequencing.

What happens after accreditation is issued?

Your URAC Specialty Pharmacy Accreditation is valid for three years. You must collect and submit annual quality measure data to URAC during the accreditation cycle. URAC may conduct a mid-cycle onsite review with 14 days' notice. IHS provides guidance on mid-cycle maintenance and can support your re-accreditation engagement beginning approximately 18 months before your cycle expires.

Related Resources

Ready to Get Started?

Schedule a no-obligation consultation with IHS. We will assess your current compliance posture, determine your eligibility for the Small Business program, and give you a clear roadmap to URAC Specialty Pharmacy Accreditation in six months or less.

Schedule a Free Discovery Session